TOTAL VOLUME:
$154.4b
24H VOL:
$290,393,159
24H TRANSACTIONS:
2,984,640,614
OPEN INTEREST:
$1,944,100,805
420,493
Markets across
40,511
events
MATCHED EVENTS:
4,612
PLATFORM COVERAGE:
5
Polymarket:
37%
VS.
Kalshi:
63%
Closed: Oct 13, 8:11 AM EST
Polymarket
As of market creation, UnitedHealth is estimated to release earnings on October 13, 2026. The Street consensus estimate for UnitedHealth’s non-GAAP EPS for the relevant quarter is $4.19 as of market creation. This market will resolve to "Yes" if UnitedHealth reports non-GAAP EPS greater than $4.19 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If UnitedHealth releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
As of market creation, UnitedHealth is estimated to release earnings on October 13, 2026. The Street consensus estimate for UnitedHealth’s non-GAAP EPS for the relevant quarter is $4.19 as of market creation. This market will resolve to "Yes" if UnitedHealth reports non-GAAP EPS greater than $4.19 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If UnitedHealth releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha. If no such figure is published within 96h of market close (4:00:00pm ET) on the day earnings are announced, the market will resolve according to the GAAP EPS listed in the company’s official earnings documents; or, if not published there, according to the GAAP EPS provided by SeekingAlpha. If no GAAP EPS number is available from either source at that time, the market will resolve to “No.” (For the purposes of this market, GAAP EPS refers to diluted GAAP EPS, unless it is not published, in which case it refers to basic GAAP EPS.) If the company does not release earnings within 45 calendar days of the estimated earnings date, this market will resolve to “No.” Note: Subsequent restatements, corrections, or revisions made to the initially announced non-GAAP EPS figure will not qualify for resolution, except in the case of obvious and immediate mistakes (e.g., fat finger errors, as with Lyft's (LYFT) earnings release in February 2024). Note: The strike prices used in these markets reflect the selected street consensus estimate for non-GAAP EPS as of market creation. Note: All figures will be rounded to the nearest cent using standard rounding. Note: For the purposes of this market, IFRS EPS will be treated as GAAP EPS. Note: If multiple versions of non-GAAP EPS are published, the market will resolve according to the primary headline non-GAAP EPS number, which is typically presented on a diluted basis. If diluted is not published, then basic non-GAAP EPS will qualify. Note: All figures are expressed in USD, unless otherwise indicated. Note: For primarily internationally listed companies, this market refers specifically to the shares traded in the United States on U.S. stock exchanges such as the NYSE or Nasdaq. In cases where the company trades in the U.S. through an American Depositary Receipt (ADR) or American Depositary Share (ADS), this market will refer to the ADR/ADS.
On Polymarket, this market is priced through a continuous auction mechanism where traders buy and sell shares representing their belief about the outcome. The price of a share directly reflects the probability of UnitedHealth beating quarterly earnings, as perceived by the market participants. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. As more traders participate and new information becomes available, the price adjusts accordingly, providing a dynamic assessment of the likelihood of a positive earnings surprise. The market’s efficiency stems from the incentive for traders to accurately predict the outcome and profit from their insights.
This market resolves around Oct 13, 2026, with the outcome confirmed once the event is verifiable from credible public reporting. Specifically, the resolution will depend on whether UnitedHealth’s reported quarterly earnings per share exceed the consensus estimate of financial analysts covering the company. The final result will be determined by a review of official earnings releases and financial news sources. Traders will then be able to claim their winnings or adjust their strategies based on the verified outcome of the earnings report.
Several factors could influence trading activity in this market leading up to resolution. Unexpected news regarding the healthcare industry, changes in regulatory policies, or significant announcements from UnitedHealth itself could all shift trader sentiment. Additionally, revisions to analyst estimates for UnitedHealth’s earnings, or broader economic indicators impacting the financial sector, could also cause the odds to fluctuate. Any information that alters the perceived likelihood of UnitedHealth exceeding earnings expectations is likely to be reflected in the price of shares in this market.